Shionogi & Co., Ltd.

Japon


 
Quantité totale PI 873
Quantité totale incluant filiales 902 (+ 29 pour les filiales)
Rang # Quantité totale PI 1 513
Note d'activité PI 3,3/5.0    367
Rang # Activité PI 1 939
Activité incl filiales 3/5.0    368
Symbole boursier
ISIN JP3347200002
Capitalisation 2363381061525.0  (JPY)
Industrie Drug Manufacturers—Specialty & Generic
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

209 33
55 10
474 42
50
 
Dernier brevet 2025 - Novel nav1.7 monoclonal antibody
Premier brevet 1975 - Antibacterial hydrazono cephalos...
Dernière marque 2025 - CINAL
Première marque 2005 - ALLERPORT

Filiales

5 subsidiaries with IP (21 patents, 8 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Beauty serums for the prevention and care of freckles and age spots; beauty serums for reducing ...
2024 Invention Content distribution apparatus, content playback apparatus, and cognitive function improvement sy...
Invention System, method, and non-transitory computer-readable recording medium. A system has an output fo...
Invention Coronavirus spike protein variants. Provided are coronavirus spike protein variants for use as an...
Invention Method for producing uracil derivative. Provided is a novel method for producing a uracil derivat...
Invention Pharmaceutical composition containing uracil derivative. The present invention provides a pharmac...
Invention Preparation containing uracil derivative. The present invention provides a preparation (pharmaceu...
Invention Condensed heterocyclic derivative having viral proliferation inhibitory activity, and pharmaceuti...
Invention Polynucleotide encoding virus-derived protein. The purpose of the present invention is to provide...
Invention Pharmaceutical preparation excellent in light stability and dissolution property. The present in...
Invention Polycyclic carbamoylpyridone derivative. The present invention provides a compound represented b...
Invention Bispecific antibody that recognizes ccr8 as antigen. Disclosed is a bispecific antibody that reco...
Invention Fused ring derivative having mgat-2 inhibitory activity. The present invention provides the comp...
Invention Pharmaceutical composition containing novel nav1.7 monoclonal antibody. The purpose of the presen...
Invention Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity. Substituted 1,...
Invention Prediction system, prediction method, and program. The present invention accurately predicts the ...
Invention Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a su...
Invention Solid dosage form having excellent stability. The present invention provides a solid dosage form...
Invention Substituted polycyclic pyridone derivatives and prodrugs thereof. The present inventon provides ...
2023 Invention Capsule or granules containing pde4 inhibitor. The purpose of the present invention is to provide...
Invention Nitrogen-containing heterocycle with serotonin receptor-binding activity and carbocyclic derivati...
Invention Use of pyridine derivative which is trpv1 antagonist. The present invention provides a novel phar...
Invention Post-operative delirium suppressant. The purpose of the present invention is to provide a prepara...
Invention Monocyclic compound having glp-1 receptor agonist activity. 11 is C(R522 is C(R633 is C(R7) or N,...
Invention Fused ring compound having glp-1 receptor agonist effect. 11 is C(R1), etc.; R1is a hydrogen atom...
Invention Substituted polycyclic carbamoyl pyridone derivative prodrug. The present invention provides a c...
Invention Bioactive peptide-containing formulation. The present invention provides a pharmaceutical composi...
Invention Signal processing device, congnitive function improvement system, signal processing method, and p...
Invention Signal processing device, earphone equipped with microphone, signal processing method, and progra...
Invention Crystal of dihydropyridinone derivative or solvate thereof. Provided is a crystal of a dihydropyr...
Invention Uracil derivatives having virus replication inhibitory activity and pharmaceutical composition co...
Invention Uracil derivative having viral growth inhibitory activity and pharmaceutical composition containi...
P/S Pharmaceutical preparations; pharmaceutical preparations for the treatment of central nervous sys...
P/S Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes...
Invention Pharmaceutical for treatment of novel coronavirus infection. The present invention provides a ph...
2022 Invention Use of opioid for treatment of autism spectrum disorders. Provided are a new pharmaceutical comp...
Invention Covid-19 treatment medicine characterized by combining 3cl protease inhibitor and covid-19 treatm...
Invention Formulation for oral administration, comprising triazine derivative. The present invention provi...
Invention Therapeutic medicine for heart disease or skeletal muscle disease. Provided is a pharmaceutical ...
Invention Novel nav1.7 monoclonal antibody. Objective of the present invention is to provide a novel Nav1....
Invention Pharmaceutical composition containing triazine derivative. The present invention provides a phar...
Invention Spiroheterocycle derivative having serotonin receptor binding activity. Provided are compounds h...
Invention Bicyclic heterocyclic derivative having viral growth inhibitory activity and pharmaceutical compo...
Invention Medicine for prevention and treatment of diseases linked to anti-obesity activity. A pharmaceuti...
P/S Acids; salts [chemical preparations]; salts [fertilisers]; salts for industrial purposes; alkalie...
P/S Acids; salts [chemical preparations]; salts [fertilisers]; salts for industrial purposes; alkali...
P/S Custom manufacture of pharmaceuticals; custom manufacturing of make-up; custom manufacture of med...
P/S mineral acids; sulfonic acids; complex salts; inorganic salts for industrial purposes; epsom salt...
P/S Pharmaceutical preparations; pharmaceuticals; medicines for human purposes; veterinary preparati...
Invention Chimeric antigen receptor that recognizes ccr8 as antigen. The chimeric antigen receptor that re...
Invention Pharmaceutical composition containing glp-1 receptor agonist having fused ring. The present inve...
P/S Anti-viral agents for human use.
P/S Pharmaceutical preparations for the treatment of infectious diseases caused by viruses; antivirals
Invention Method for detecting and quantifying nucleic acid from environmental samples. The present invent...
P/S Pharmaceutical preparations; vaccines.
Invention Cationic lipid. The present invention provides novel cationic lipids having excellent encapsulat...
P/S Chemistry apparatus and instruments for laboratory use, namely, laboratory chemical reactors, gla...
P/S Chemistry apparatus and instruments; laboratory apparatus and instruments; precision measuring m...
2021 Invention Cyclic amine derivatives having serotonin receptor binding activity. Provided are a compound hav...
P/S anti-viral agents for human use.
Invention Condensed heterocyclic compound. A condensed heterocyclic compound has a sepiapterin reductase i...
P/S Diagnostic preparations for medical purposes Medical diagnostic apparatus for testing for viruses...
P/S Pharmaceutical preparations; diagnostic preparations for medical purposes. Medical apparatus and...
P/S Pharmaceutical preparations; Diagnostic preparations for medical purposes. Medical apparatus and ...